Showing 1621-1640 of 8875 for: Cochrane Systematic Reviews Back
- Cognitive rehabilitation for attention deficits following stroke
Cochrane Systematic Reviews, 10-Nov-2019
Many survivors of stroke report attentional impairments, such as diminished concentration and distractibility. However, the effectiveness of cognitive rehabilitation for improving these impairments is uncertain.This is an update of the Cochrane Review fir
- Cognitive rehabilitation for executive dysfunction in adults with stroke or other adult non-progressive acquired brain damage
Cochrane Systematic Reviews, 5-Mar-2013
Executive functions are the controlling mechanisms of the brain and include the processes of planning, initiation, organisation, inhibition, problem solving, self monitoring and error correction. They are essential for goal-oriented behaviour and respondi
- Cognitive rehabilitation for memory deficits after stroke
Cochrane Systematic Reviews, 1-Sep-2016
Memory problems are a common cognitive complaint following stroke and can potentially affect ability to complete functional activities. Cognitive rehabilitation programmes either attempt to retrain lost or poor memory functions, or teach patients strategi
- Cognitive rehabilitation for people with schizophrenia and related conditions
Cochrane Systematic Reviews, 24-Jul-2000
Researchers have consistently found that people with schizophrenia score more poorly than others on a wide array of cognitive tasks and that these deficits persist even when the illness is in remission. The perceived impact of cognitive impairment on day-
- Cognitive stimulation to improve cognitive functioning in people with dementia
Cochrane Systematic Reviews, 31-Jan-2023
Cognitive stimulation (CS) is an intervention for people with dementia offering a range of enjoyable activities providing general stimulation for thinking, concentration and memory, usually in a social setting, such as a small group. CS is distinguished f
- Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
Cochrane Systematic Reviews, 5-Jun-2013
Cognitive impairments, particularly memory problems, are a defining feature of the early stages of Alzheimer's disease (AD) and vascular dementia. Cognitive training and cognitive rehabilitation are specific interventional approaches designed to address d
- Cognitive training for people with mild to moderate dementia
Cochrane Systematic Reviews, 25-Mar-2019
Cognitive impairment, a defining feature of dementia, plays an important role in the compromised functional independence that characterises the condition. Cognitive training (CT) is an approach that uses guided practice on structured tasks with the direct
- Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
Cochrane Systematic Reviews, 26-Feb-2020
Approximately 60% to 80% of people with Parkinson's disease (PD) experience cognitive impairment that impacts on their quality of life. Cognitive decline is a core feature of the disease and can often present before the onset of motor symptoms. Cognitive
- Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment
Cochrane Systematic Reviews, 12-Nov-2008
Cognitive-behavioral therapy (CBT) appears to be effective in the treatment of antisocial behavior both in adolescents and adults. Treatment of antisocial behavior in youth in residential settings is a challenge since it usually involves more serious beha
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
Cochrane Systematic Reviews, 23-Mar-2018
Attention deficit hyperactivity disorder (ADHD) is a developmental condition characterised by symptoms of inattention, hyperactivity and impulsivity, along with deficits in executive function, emotional regulation and motivation. The persistence of ADHD i
- Cognitive‐behavioural interventions for children who have been sexually abused
Cochrane Systematic Reviews, 16-May-2012
Despite differences in how it is defined, there is a general consensus amongst clinicians and researchers that the sexual abuse of children and adolescents ('child sexual abuse') is a substantial social problem worldwide. The effects of sexual abuse manif
- Cognitive-behavioural interventions for preventing youth gang involvement for children and young people (7-16)
Cochrane Systematic Reviews, 11-Nov-2008
Many studies document a robust and consistent relationship between gang membership and elevated delinquency, with gang members disproportionately involved in crime compared to non-gang peers. Research also indicates that both delinquent youth and youth wh
- Cognitive‐behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour
Cochrane Systematic Reviews, 23-Jun-2020
Around 1 in 1000 adolescents aged 12 to 17 years old display problematic or harmful sexual behaviour (HSB). Examples include behaviours occurring more frequently than would be considered developmentally appropriate; accompanied by coercion; involving chil
- Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders
Cochrane Systematic Reviews, 17-Dec-2018
Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances. ATS are highly addictive and prolonged use may result in a series of menta
- Cognitive‐behavioural treatment for subacute and chronic neck pain
Cochrane Systematic Reviews, 26-May-2015
Although research on non-surgical treatments for neck pain (NP) is progressing, there remains uncertainty about the efficacy of cognitive-behavioural therapy (CBT) for this population. Addressing cognitive and behavioural factors might reduce the clinical
- Colchicine as an oral corticosteroid sparing agent for asthma
Cochrane Systematic Reviews, 5-Nov-2009
Oral corticosteroids are used as a treatment for asthma, but they are often associated with serious side effects. Colchicine is an anti-inflammatory, immuno modulating agent, which could potentially have a beneficial effect in the treatment of asthma as w
- Colchicine for acute gout
Cochrane Systematic Reviews, 26-Aug-2021
This is an updated Cochrane Review, first published in 2006 and updated in 2014. Gout is one of the most common rheumatic diseases worldwide. Despite the use of colchicine as one of the first-line therapies for the treatment of acute gout, evidence for it
- Colchicine for alcoholic and non‐alcoholic liver fibrosis and cirrhosis
Cochrane Systematic Reviews, 20-Apr-2005
Alcohol and hepatotropic viruses cause the majority of liver cirrhosis in the Western World. Colchicine is an anti-inflammatory and anti-fibrotic medication. Several randomised clinical trials have addressed the question whether colchicine has any efficac
- Colchicine for pericarditis
Cochrane Systematic Reviews, 19-Aug-2014
Pericarditis is the inflammation of the pericardium, the membranous sac surrounding the heart. Recurrent pericarditis is the most common complication of acute pericarditis, causing severe and disabling chest pains. Recurrent pericarditis affects one in th
- Colchicine for prevention of cardiovascular events
Cochrane Systematic Reviews, 27-Jan-2016
Colchicine is an anti-inflammatory drug that is used for a wide range of inflammatory diseases. Cardiovascular disease also has an inflammatory component but the effects of colchicine on cardiovascular outcomes remain unclear. Previous safety analyses wer
